ZURICH, May 26 (Reuters) - Swiss drugmaker Novartis said on Monday its Extavia multiple sclerosis drug had been approved in the European Union and repeated that it planned to launch Extavia in the U.S. and Europe in the first half of 2009.
ZURICH, May 26 (Reuters) - Swiss drugmaker Novartis said on Monday its Extavia multiple sclerosis drug had been approved in the European Union and repeated that it planned to launch Extavia in the U.S. and Europe in the first half of 2009.
